Clovis Oncology (CLVS) Tops Q1 EPS by 8c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($0.64), $0.08 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $38.05 million versus the consensus estimate of $44.05 million.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c